Table 1.

Estimates of acute GVHD incidence and mortality after SOT, alloHCT, and transfusions

Transplant type2020 US transplants, n GVHD incidenceGVHD mortality, %
Solid organs    
Kidney 22 817 Very low6,7  30-506-9  
Liver 8 906 0.1%-2%4,10  >604,10  
Lung/HL 2 539/58 Very low11,12  >8011,13,14  
Intestine 91 5%-10%5,15  40-7016  
AlloHCT 9 026 30%-70%17  30-5018,19  
Transfusions 15 280  000§ 20  Very low 21  9021  
Transplant type2020 US transplants, n GVHD incidenceGVHD mortality, %
Solid organs    
Kidney 22 817 Very low6,7  30-506-9  
Liver 8 906 0.1%-2%4,10  >604,10  
Lung/HL 2 539/58 Very low11,12  >8011,13,14  
Intestine 91 5%-10%5,15  40-7016  
AlloHCT 9 026 30%-70%17  30-5018,19  
Transfusions 15 280  000§ 20  Very low 21  9021  

HL, combined heart-lung transplantation.

Numbers of solid organ transplants and allogeneic hematopoietic cell transplants in the United States based on data from the Organ Procurement and Transplantation Network and Center for International Blood and Marrow Transplant Research, both accessed on 1 March 2022.

Five cases reported in world literature.

Twelve cases reported in world literature.

§

Transfusion numbers are the estimated total units of red blood cells, platelets, and plasma transfused in 2019 in the United States based on the National Blood Collection and Utilization Survey.

Fifty cases reported in the United States from 1966 to 2013.

or Create an Account

Close Modal
Close Modal